Sangamo Therapeutics (SGMOQ) EBITDA Margin (2009 - 2026)
Sangamo Therapeutics' EBITDA Margin came in at -2165.53% for Q1 2026, down 1721.10 percentage points from -444.43% a year earlier and down 1904.04 percentage points from the prior quarter.
Sangamo Therapeutics (SGMOQ) EBITDA Margin (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Mar 31, 2026, Sangamo Therapeutics reported EBITDA Margin of -346.84%, down 225.52 percentage points year-over-year; for FY2025, it came in at -296.42%, down 125.38 percentage points from FY2024.
- EBITDA Margin carries a five-year change of -191.63 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was -171.04% in FY2024 (-24.13 pp), -146.91% in FY2023 (+23.06 pp), -169.97% in FY2022 (-12.88 pp) and -157.09% in FY2021 (-52.30 pp).
- The five-year range for quarterly EBITDA Margin is -10419.96% (Q1 2024) to 23.98% (Q3 2024).
- Year-over-year, EBITDA Margin increased in five of the last eight quarters, with an average year-over-year change of +964.90 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in Q2 2025 (a gain of 9975.87 percentage points), and the weakest in Q1 2024 (a drop of 10433.58 percentage points).
- Business Quant data shows SGMOQ's EBITDA Margin at -261.49% (Q4 2025), -5949.05% (Q3 2025) and -92.11% (Q2 2025) in the three quarters before Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | Sangamo Therapeutics | 45.57 Mn | -70.94 Mn | - | -2,165.53% |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -2,165.53% |
| Dec 31, 2025 | -261.49% |
| Sep 30, 2025 | -5,949.05% |
| Jun 30, 2025 | -92.11% |
| Mar 31, 2025 | -444.43% |
| Dec 31, 2024 | -327.76% |
| Sep 30, 2024 | 23.98% |
| Jun 30, 2024 | -10,067.98% |
| Mar 31, 2024 | -10,419.96% |
| Dec 31, 2023 | -2,947.94% |
| Sep 30, 2023 | -1,073.79% |
| Jun 30, 2023 | -1,745.66% |
| Mar 31, 2023 | 13.63% |
| Dec 31, 2022 | -191.15% |
| Sep 30, 2022 | -195.94% |
| Jun 30, 2022 | -145.86% |
| Mar 31, 2022 | -150.29% |
| Dec 31, 2021 | -131.08% |
| Sep 30, 2021 | -158.32% |
| Jun 30, 2021 | -163.41% |
Sangamo Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SGMOQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "SGMOQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();